Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

Phillip Parente*, Francis Parnis, Howard Gurney

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective'. Together they form a unique fingerprint.

Medicine & Life Sciences